ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00678626
Recruitment Status : Withdrawn
First Posted : May 15, 2008
Last Update Posted : May 4, 2015
Sponsor:
Information provided by:
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : September 2011
  Estimated Study Completion Date : September 2011